Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, Fontana L. Assessment of autonomic function in untreated adult coeliac disease. World J Gastroenterol 2004; 10(18): 2715-2718 [PMID: 15309725 DOI: 10.3748/wjg.v10.i18.2715]
Corresponding Author of This Article
Dr. Antonio Tursi, Galleria Pisani, 4, 70031 Andria (BA), Italy. antotursi@tiscali.it
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Giovanni Brandimarte, Department of Internal Medicine, Division of Gastroenterology, “Cristo Re” Hospital, Rome, Italy
Ambrogio Capria, Luigi Fontana, Department of Internal Medicine and Immunology, “Tor Vergata” University, Rome, Italy
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Antonio Tursi, Galleria Pisani, 4, 70031 Andria (BA), Italy. antotursi@tiscali.it
Fax: +39-883-290225
Received: January 10, 2004 Revised: January 29, 2004 Accepted: March 2, 2004 Published online: September 15, 2004
Abstract
AIM: Some recent studies showed that alteration of upper-gut motility in coeliac disease may be related to dysfunction of autonomic nervous system. The aim of our study was to investigate whether autonomic nervous system was altered in untreated and unselected coeliac disease patients.
METHODS: We studied 8 untreated and consecutive coeliac disease patients (2 males and 6 females, age range 37 ± 14.5 years). Histological evaluation of duodenal mucosa, anti-gliadin antibodies (AGA), antiendomysial antibodies (EMA) and anti-tTG antibodies and sorbitol H2 breath test were performed in all patients. Extrinsic autonomic neuropathy was assessed by the standardized measurement of cardiovascular reflexes (lying-to-standing, Valsalva manoeuvre, deep breathing, sustained handgrip). The results obtained were compared with a healthy, asymptomatic control group (6 males and 7females, age range 42.3 ± 13.5 years).
RESULTS: Coeliac patients exhibited a lower increase of PAS as a response to isometric effort, a reduction of spectral power LF as a response to clinostatic position, but without statistical significance. Also they showed a lower tolerance to orthostatic position, associated with a latent disequilibrium of sympathetic-vagal balance, a relative prevalence of parasympathetic component of the autonomic function. However, these results were not statistically significant when compared with control group (P = n.s.). And they were unchanged after 6 and 12 mo of gluten-free diet.
CONCLUSION: This study failed to confirm a significant correlation between autonomic dysfunction and coeliac disease, yet we could not exclude a role of autonomic dysfunction in the genesis of systemic symptoms in some coeliacs.
Key Words: $[Keywords]
Citation: Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, Fontana L. Assessment of autonomic function in untreated adult coeliac disease. World J Gastroenterol 2004; 10(18): 2715-2718
Coeliac disease (CD) is the most common severe food intolerance in the Western world[1]. It is a clinical syndrome of intestinal malabsorption, a characteristic though not specific histological lesion involving total, subtotal or partial small bowel villous atrophy (predominating in its proximal segments). It is the result of sensitiveness to ingested gluten in genetically susceptible people with the subsequent immune reaction leading to small bowel inflammation[2]. The classical malabsorptive symptoms of diarrhoea and weight loss are only one aspect of the spectrum of manifestations of this relatively common disease[3,4], since symptoms may be subtle and many patients have subclinical or silent disease[5,6]. A proper gluten-free diet (GFD) would lead to a clinical and histological improvement[7-9]. In particular, GFD played a key role in preventing nutritional deficiency, especially of micronutrients, and in reducing the risk of the development of intestinal malignancies[10].
It is quite frequently seen in clinical practice that coeliac patients present gastrointestinal motor abnormalities[11]. It has been recently shown that alteration of upper-gut motility may be related to dysfunction of autonomic nervous system[12]. The aim of our study was to investigate whether autonomic nervous system (ANS) was altered even in untreated and unselected coeliac patients and to assess the effect of GFD on ANS dysfunctions.
MATERIALS AND METHODS
Patients
We studied 8 untreated, consecutive and unselected coeliac disease patients (2 males and 6 females, age range 37 ± 14.5 years). Both the original[13] and revised[7] criteria for the diagnosis of CD were used in this study. CD was defined as a permanent gluten-sensitive enteropathy, primarily manifested by the presence of characteristic small intestinal lesions[14]. Small-bowel biopsy was performed in all patients, as well as esophagogastroduodenoscopy (Fujinon EG300 videogastroscope; Fujinon, Omiya, Japan). At least six small-bowel biopsies were obtained from the second part of the duodenum using a disposable biopsy forceps with spike (U.S. Endoscopy Inc., Mentor, Ohio, U.S.A.) and evaluated by haematoxylin/eosin staining. Histopathology was expressed according to the Marsh classification of 1992[15]: “infiltrative” lesions with > 30 lymphocytes/100 epithelial cells were defined as Marsh type I, “infiltrative/hyperplastic” lesions as Marsh II and “partial (sub) total” villous atrophy (VA) as type III. We subdivided the Marsh III type into partial VA (Marsh IIIa), subtotal VA (Marsh IIIb) and total VA (Marsh IIIc), according to Oberhuber’s modified classification[16].
Other possible causes of villous atrophy or duodenal damage, such as Giardia Lamblia infection, tropical sprue, collagenous sprue, food protein hypersensitiveness (cow’s milks, eggs, fish, rice, chicken) were excluded, as well as other causes of inflammatory infiltration of duodenum, such as peptic duodenitis[16].
Methods
IgA and IgG anti-gliadin antibodies (AGA) were measured in all patients by enzyme-linked immunosorbent assay (kit Alfagliatest, Eurospital, Trieste - Italy); the lower limit of positivity of IgA-class was 0.2 EU/mL and of IgG-class 10.0 EU/mL. IgA antiendomysial antibodies (EMA) were screened by the indirect immunofluorescent method on monkey oesophagus (kit Antiendomysium, Eurospital, Trieste - Italy). IgA anti-tissue transglutaminase antibodies were also screened by enzyme-linked immunosorbent assay using human recombinant tTG (kit Eu-tTG, Eurospital, Trieste - Italy); the lower limit of positivity of these antibodies was 7 UA/mL.
Also sorbitol H2 breath test (H2-BT) was performed. All patients were studied after an overnight fasting having been instructed to consume a meal of rice and meat; they were also requested not to smoke on the morning of the test day. End expiratory samples were collected before the patients drank the test solution (5 g of sorbitol in 150 mL of tap water) and every 30 min for 4 h. Hydrogen concentrations in each collected sample were measured with a breath-hydrogen analyzer (EC60 Gastrolyzer Breath Hydrogen Monitor, Bedfont Scientific Ltd, Upchurch - Kent, England [U.K.]). An increase in H2 concentration of at least 20 ppm over fasting baseline was considered positive for sorbitol malabsorption. The cut-off for calculating the validity of the test was shifted every 30 min, and a response operating characteristics (ROC) curve was plotted on the basis of the obtained results.
The clinical, endoscopic, histological and serological pattern of the studied coeliacs are described in Table 1, Table 2.
Table 1 Demographic, clinical, endoscopic and histological data of the coeliac patients.
Patient No.
Sex
Age (yr)
Clinical finding
Endoscopic finding
Histology
1
F
71
Weakness, diarrhoea
Absence of Kerckring’s folds
Marsh IIIc
2
M
58
Diarrhoea, weight loss
Absence of Kerckring’s folds
Marsh IIIb
3
F
31
Aphtous stomatitis, IDA
Reduction of Kerckring’s folds
Marsh IIIb
4
F
31
IDA
“Scalloping” of duodenal folds
Marsh IIIa
5
F
38
Diarrhoea, abdominal pain, weight loss
Reduction of Kerckring’s folds, micronodular mucosa
Marsh IIIc
6
M
33
IDA
Reduction of Kerckring’s folds
Marsh IIIa
7
F
24
IDA, Grave’s disease
Reduction of Kerckring’s folds
Marsh IIIa
8
F
32
IDA, weakness
Reduction of Kerckring’s folds
Marsh IIIa
Table 2 Non-invasive tests in the studied coeliac population.
Patient No.
AGA IgA
AGA IgG
EMA
Anti-tTG
Sorbitol H2-BT
1
+
+
+
+
+
2
+
+
+
+
+
3
+
+
+
+
+
4
+
+
-
-
+
5
+
+
+
+
+
6
+
+
-
+
+
7
-
-
+
-
+
8
+
-
-
+
+
No patient had other associated organic (such as hereditary, toxic, infectious, inflammatory) or metabolic diseases.
Extrinsic autonomic neuropathy was assessed by the standardized measurement of cardiovascular reflexes. Tests were performed in the morning and at constant temperatures. Autonomic function was evaluated by means of electrocardiograph Personal 120 (Esaote Biomedica, Firenze, Italy) and a Finapress set (Ohmeda, Louisville, Colorado, USA). We evaluated the heart rate variation (R-R interval) and systolic (SBP) and diastolic (DBP) blood pressures in response to a variety of stimuli: lying-to-standing (evaluation of R-R variation with a 30.15 ratio); Valsalva manoeuvre (forced expiration for 15 s with a 40 mm Hg pressure); deep breathing (6 expiratory cycles throughout one minute, evaluating the average of differences between the maximal and minimal duration of R-R interval during three subsequent deep breath [DB3]); sustained handgrip (performing isometric sub-maximal work for 3 min and evaluating blood pressure and heart rate variations); and tilt tests. The results of each test were scored according to Ewing’s modified criteria[17,18].
The results obtained were compared with a healthy, asymptomatic control group (13 people, 6 males and 7 females, age range 42.3 ± 13.5 years). All coeliac patients were re-evaluated about the autonomic function 6 and 12 mo after GFD has started.
Statistical analysis
The Student’s t-test for unpaired data was used, and data are presented as mean ± SD. P < 0.05 was considered as statistically significant.
RESULTS
We noted that coeliac patients showed a lower increase of PAS in response to isometric effort. Moreover, they showed a reduction of spectral power LF in response to clinostatic position, but without statistical significance (Table 3, Table 4).
Table 3 Evaluation of autonomic function in coeliac patients and control group.
Group
LS
VR
DB
△PAS Handgrip
△PAD Handgrip
Coeliac disease
1.22 ± 0.1
1.73 ± 0.38
35.5 ± 16.4
35.7 ± 16.4
24.6 ± 13.2
Control group
1.24 ± 0.19
1.62 ± 0.25
32.5 ± 7.67
55.5 ± 24.2
27.1 ± 11.1
P
NS
NS
NS
NS
NS
Table 4 Evaluation of Heart rate variance in coeliac patients and control group.
Group
LF Clino
LF Ortho
HF Clino
HF Ortho
LF/HF Clino
LF/HF Ortho
Coeliac disease
35.9 ± 18.1
73.5 ± 15.3
35.7 ± 18.9
13.21 ± 9.3
1.56 ± 1.85
8.63 ± 6.34
Control group
52.8 ± 21.0
67.1 ± 25.9
31.1 ± 15.6
17.90 ± 12.9
2.35 ± 1.65
6.94 ± 5.5
P
NS
NS
NS
NS
NS
NS
Only one female patient (Table 5, patient number 8) showed symptomatic orthostatic hypotension (defined as SBP decrease >/= 20 mm Hg and DBP >/= 10 mmHg within 3 min in orthostatic position) as responsiveness to orthostatic position.
Table 5 Overall results of autonomic tests in coeliac patients.
Patient No.
Basal SBP
Basal DBP
Ortho SBP
Ortho DBP
Clino. LF
Ortho. LF
Clino. HF
Ortho.HF
Clino. LF/HF
Ortho. LF/HF
LS
VR
DB
Syst. SH
Diast.SH
Syst. Tilt Test
Diast. Tilt Test
1
127
82
120
82
40.99
61.65
48.00
32.82
0.85
1.88
1.03
1.46
19.2
54
27
-9
7.00
2
130
87
135
87
21.41
60.74
30.09
10.73
0.71
5.66
1.37
1.90
35.9
36
14
-9
5.00
3
130
80
125
80
77.04
92.52
12.89
5.96
5.98
15.52
1.20
1.40
33.3
35
25
19
14.00
4
105
70
105
85
38.26
63.87
20.19
17.85
1.9
3.58
1.20
2.30
40.1
39
36
3
7.00
5
115
80
120
82
31.15
58.43
62.16
16.49
0.5
3.54
1.20
1.40
39.3
48
28
7
14.00
6
120
80
108
75
27.16
87.79
27.33
11.00
0.99
7.98
1.18
1.50
40.2
50
47
2
12.00
7
105
70
115
75
20.30
94.00
61.00
4.79
0.3
19.6
1.30
2.30
44.3
7
6
-7
15.00
8
115
70
80
60
30.93
68.81
23.81
6.06
1.3
11.35
1.30
1.60
31.8
17
14
-10
2.00
Mean
118.38
77.38
113.50
78.25
35.91
73.48
35.68
13.21
1.57
8.64
1.22
1.73
35.51
35.75
24.63
-0.50
9.50
SD
10.20
6.52
16.50
8.51
18.13
15.27
18.88
9.28
1.85
6.34
0.10
0.39
7.74
16.37
13.20
10.23
4.87
The overall results of ANS in coeliacs showed a tendency to lower systolic-diastolic values of blood pressure both in clinostatic position and in active and passive orthostatic positions. However, these results had no statistical difference compared with those of control group (Table 4).
The spectral analysis of heart rate variance (HRV), performed with autoregressive method, confirmed these findings. The autoregressive analysis of HRV showed an important, but not significant, reduction of the power LF according to a considerable reductive activity of sympathetic tone at rest with a relative prevalence of parasympathetic tone. Passive orthostatic, evaluated by tilt tests, induced a marked sympathetic response (with increase of spectral power LF) (Table 5).
All patients were re-evaluated about the autonomic function 6 and 12 mo after GFD has started. In none of them we noted change of the results, and the symptomatic orthostatic hypotension persisted in patient number 8 despite strict adherence to GFD.
DISCUSSION
In recent years a discrete frequency of autonomic neuropathy has been disclosed in coeliac patients[12,19], similar to that reported in other functional gastrointestinal disorders, but lower than that described in diabetic subjects[20]. Pathogenetic factors involved in autonomic dysfunction in coeliac disease were unknown, and autoimmune damage or metabolic derangement have been hypothesized[21-23].
We investigated our coeliac patients, exploring their autonomic function using the cardiovascular tests because they were easily available reproducible, and not very expensive[24,25]. Our study showed quite different results from those recent studies about autonomic function in coeliacs. In particular, they differed from Usai’s study, which reported ANS abnormalities in 45% of coeliacs affected by upper gastrointestinal symptoms[12]. Thus, we can hypothesize that ANS abnormalities may play a role in upper gastrointestinal symptoms rather than in systemic symptoms. In fact we recorded ANS abnormalities only in 1/5 patient without gastrointestinal symptoms. On the other hand, it is noteworthy that we did not find ANS abnormalities in any of the 3 patients complaining about gastrointestinal symptoms (Table 5). However, a role of ANS dysfunction in some coeliac patients cannot be excluded, since the patient No. 8 of our studied population (a 32-year-old female), the only one with ANS dysfunction, did not show dyspeptic symptoms but only systemic symptoms.
What a role could then the autonomic neuropathy play? Can it really play a role in the systemic symptoms in coeliac disease? We knew that several coeliac patients experienced weakness or chronic fatigue in clinical practice. In most cases it was related to malabsorption (such as iron-deficiency anaemia or folic acid deficiency), but in some cases autonomic neuropathy might be suspected. Our study unfortunately failed to demonstrate a significant autonomic dysfunction in CD; however, we cannot exclude that in some patients ANS dysfunction might play a role in the genesis of some systemic symptoms, such as weakness or chronic fatigue. In fact we noted that coeliac patients showed a lower tolerance to orthostatism, associated with a latent disequilibrium of sympathetic-vagal balance, ie, a relative prevalence of the parasympathetic component of the autonomic function. These alterations, and in particular the reduced tolerance to orthostatism, may explain the above mentioned symptoms in some cases, as we noted in patient No. 8 (Table 5).
But another very finding was that ANS dysfunction did not improve in this patient after GFD. It is difficult to explain why ANS did not improve after gluten withdrawal. We speculate that ANS dysfunction may be a two step process. In the first phase it may be gluten-related, and may improve after GFD. This phase may have a variable length, probably related to age, gender and time to gluten exposure. In the second phase it may be gluten-independent, probably related to autoimmune axonal aggression to autonomic nervous system, in which autoimmunity may perpetuate the neurological damage. Recent studies of Luostarinen et al[26] may in part confirm this hypothesis. They showed that axonal neuropathy in CD might be also subclinical without any sign of malabsorption and it often persisted despite good compliance to GFD[26]. This hypothesis may justify the persistence of the orthostatic hypotension in patient 8 after six and twelve months of GFD, and it may also explain why some coeliacs experienced persistence or recurrence of chronic fatigue despite GFD. We consider that the recurrence of systemic symptoms is related to incidental gluten ingestion from unknown sources: the autonomic neuropathy, with consequent disequilibrium of sympathetic-vagal balance may be the cause of these systemic symptoms.
Tursi A, Giorgetti G, Brandimarte G, Rubino E, Lombardi D, Gasbarrini G. Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation.Hepatogastroenterology. 2001;48:462-464.
[PubMed] [DOI][Cited in This Article: ]
Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice?Minerva Gastroenterol Dietol. 2002;48:121-130.
[PubMed] [DOI][Cited in This Article: ]
Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').Gastroenterology. 1992;102:330-354.
[PubMed] [DOI][Cited in This Article: ]
